We are international
Donate
• health professionals TEXT SIZE   
webcasts    back

Amplification of 1q21 Is Associated with Poor Outcome after Treatment with Bortezomib in Relapsed/Refractory Multiple Myeloma
By Heinz Ludwig, MD
12.17.06
Amplification of 1q21 Is Associated with Poor Outcome after Treatment with Bortezomib in Relapsed/Refractory Multiple Myeloma



 related articles